Mineralys Therapeutics, Inc.

NASDAQ:MLYS

Biotechnology

Healthcare
$14.16 +1.49%

+$0.37 today

Market cap
$1.25B
Beta
0.56
P/E (TTM)
-13.9
EPS (TTM)
-$1.83
52W Low $12.59High $47.65

Volume 1.17M

Average 1.48M

Price history

Mineralys Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-66.18%

Period high

$43.36

Period low

$13.78

Latest

$14.16

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 4, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
8-KOct 29, 2026Oct 29, 2026
4Oct 20, 2026Oct 20, 2026
3Oct 20, 2026Oct 20, 2026
3Oct 20, 2026Oct 20, 2026
4Oct 20, 2026Oct 20, 2026
8-KOct 19, 2026Oct 19, 2026
4Oct 2, 2026Oct 2, 2026
4Sep 24, 2026Sep 24, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 17, 2026Sep 17, 2026
4Aug 25, 2026Aug 25, 2026
3Aug 12, 2026Aug 12, 2026
4Aug 12, 2026Aug 12, 2026

Competitors

Who does Mineralys Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about MLYS's filings, answered from its disclosures.

What is the latest MLYS filing?

The latest filing shown is 8-K dated Nov 4, 2026.

How many recent filings does MLYS have?

Intrinsic Alpha currently shows 20 recent filings for MLYS.